戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  neurons) that underlie the chronic phase of painful neuropathy.
2 get of several disorders, including a common painful neuropathy.
3 to paclitaxel-induced acute pain and chronic painful neuropathy.
4 and peripheral nerve axons, in patients with painful neuropathy.
5  mutations are associated with two inherited painful neuropathies.
6 to innocuous light touching, is a symptom of painful neuropathies.
7                  There were 22 patients with painful neuropathy and 28 without pain, 26 with sensory
8 hannel function associated with an inherited painful neuropathy and suggest that these physiological
9 D in diabetic rodents exhibiting features of painful neuropathy and the translational potential of th
10                             Patients develop painful neuropathy and vascular occlusions that progress
11 rial environment and the pathogenesis of the painful neuropathies associated with the macrophage-depe
12 asis of erythermalgia, an autosomal dominant painful neuropathy characterized by redness of the skin
13 ate that a variant of NaV1.7 associated with painful neuropathy depolarizes resting membrane potentia
14       Sixteen subjects presenting with acute painful neuropathy had neurological and retinal examinat
15 on injury (CCI) to peripheral nerve causes a painful neuropathy in association with a process of axon
16 therapy drugs for treating many cancers, and painful neuropathy is a major dose-limiting adverse effe
17 V1.8 mRNA in the pathogenesis of SNE-induced painful neuropathy, NaV1.8 shRNA vector was delivered by
18                                         This painful neuropathy not only affects the quality of life
19  occurred in < or = 10% of patients; grade 2 painful neuropathy occurred in 7.5%; and grade 3 palmar-
20 or sources of disability and often result in painful neuropathies or the impairment of muscle movemen
21 mol/l], and the mean was higher still in the painful neuropathy subgroup [92.2 (37.1) mmol/l] (P < 0.
22  was not significant (P = 0.45), even in the painful neuropathy subgroup.
23  in the injured nerve and the development of painful neuropathy symptoms.
24 ility and familial episodic pain disorder or painful neuropathy, while mutations evoking larger membr
25 id substrate of this enzyme, leads to severe painful neuropathy with progressive renal, cardiovascula

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。